B Kinase
Kyu-Jin Park,1,
Byung-Yoon Ahn,2
Guhung Jung,3
Michael M. C. Lai,4 and
Soon B. Hwang1*
Ilsong Institute of Life Science, Hallym University, Chuncheon 200-702, South Korea,1 School of Science and Biotechnology, Korea University, Seoul 136-701, South Korea,2 School of Biological Sciences, Seoul National University, Seoul 151-742, South Korea,3 Department of Molecular Microbiology and Immunology, University of Southern California School of Medicine, Los Angeles, California 900334
Received 13 June 2005/ Returned for modification 25 July 2005/ Accepted 23 January 2006
Hepatitis C virus (HCV) NS5B protein is a membrane-associated phosphoprotein that possesses an RNA-dependent RNA polymerase activity. We recently reported that NS5A protein interacts with TRAF2 and modulates tumor necrosis factor alpha (TNF-
)-induced NF-
B and Jun N-terminal protein kinase (JNK). Since NS5A and NS5B are the essential components of the HCV replication complex, we examined whether NS5B could modulate TNF-
-induced NF-
B and JNK activation. In this study, we have demonstrated that TNF-
-induced NF-
B activation is inhibited by NS5B protein in HEK293 and hepatic cells. Furthermore, NS5B protein inhibited both TRAF2- and IKK-induced NF-
B activation. Using coimmunoprecipitation assays, we show that NS5B interacts with IKK
. Most importantly, NS5B protein in HCV subgenomic replicon cells interacted with endogenous IKK
, and then TNF-
-mediated IKK
kinase activation was significantly decreased by NS5B. Using in vitro kinase assay, we have further found that NS5B protein synergistically activated TNF-
-mediated JNK activity in HEK293 and hepatic cells. These data suggest that NS5B protein modulates TNF-
signaling pathways and may contribute to HCV pathogenesis.
These authors contributed equally to this work.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|